More broadly: Employer coverage is scaling fast: 64% of Americas largest employers now cover weight-loss drugs, up from 56% a year ago (source) PBMs are locking in controls: CVS Caremark, Express Scripts, Optum Rx, and Prime are adding GLP1s to formularies with step edits, prior auths, and exclusions (source) Were at a real infection point
For research protocols focused on body composition changes, particularly fat reduction, AOD-9604 offers a targeted approach
At the heart of this transformation are GLP-1-based therapies, a class of drugs that has rapidly moved from diabetes treatment into the center stage of obesity care and beyond
The amount of product needed for the treatment is fully dependant on the extension of the area to be treated, so body areas are bound to be different from person to person
Making unilamellar liposomes using focused ultrasound
Can I increase my natural GLP-1 production without medication